TickerFacts.

Coya Therapeutics, Inc. (COYA): Operating Cash Flow

Annual figures by period end, from SEC filings.

-$10.74M
Year ended 2025-12-31
-$15.72M
Trailing 12 months to 2026-06-30
2021-12-31: -$3.90M2022-12-31: -$7.24M2023-12-31: -$11.19M2024-12-31: -$10.29M2025-12-31: -$10.74M-$10.74M
2021-12-31 Operating Cash Flow (USD) 2025-12-31
Period endedOperating Cash FlowChange YoYSource filing
2025-12-31-$10.74Mn/m2026-03-16, From 2025-01-01
2024-12-31-$10.29Mn/m2026-03-16, From 2024-01-01
2023-12-31-$11.19Mn/m2025-03-18, From 2023-01-01
2022-12-31-$7.24Mn/m2024-03-19, From 2022-01-01
2021-12-31-$3.90Mn/a2023-03-29, From 2021-01-01

Operating Cash Flow at similar companies

Companies with the same SEC industry code (Pharmaceutical Preparations), reporting in the same currency, closest in revenue. Each shows its own latest fiscal year, so period ends differ.

CompanyYear endedOperating Cash FlowChange YoY
Coya Therapeutics, Inc. (COYA)2025-12-31-$10.74Mn/m
Aclaris Therapeutics, Inc. (ACRS)2025-12-31-$47.11Mn/m
Bolt Biotherapeutics, Inc. (BOLT)2025-12-31-$39.85Mn/m
Adagene Inc. (ADAG)2025-12-31-$15.66Mn/m
Roivant Sciences Ltd. (ROIV)2026-03-31-$750.35Mn/m
Xenon Pharmaceuticals Inc. (XENE)2025-12-31-$279.12Mn/m
Ovid Therapeutics Inc. (OVID)2025-12-31-$38.33Mn/m
Whitehawk Therapeutics, Inc. (WHWK)2025-12-31-$97.43Mn/m
BioAge Labs, Inc. (BIOA)2025-12-31-$81.63Mn/m

Compare COYA, ACRS, BOLT, ADAG side by side · Screen every company in Pharmaceutical Preparations ↗